🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

A very nice paper in Blood Advances by Dr Wieduwilt on clinical trial endpoints in ALL studies and highlighting the heterogeneity across various Phase II/III studies ashpublications.org/bloodadvances/…

A new standard of care in high-risk APL? #EHA24

The UNM Comprehensive Cancer Center was strongly represented over the weekend at Beyond Trauma Foundation's Best of ASCO Conference in Albuquerque. Congratulations to all the presenters.

Our analysis of intensive chemo (IC) in CBF-AML (200 pt) is out in eJHaem Journal! Kudos to lead author Alexandra Rojek We found: -similar EFS/OS betw IC + GO & IC alone -longer 3y EFS w/ IC + KIT inhibitor (85%) we eagerly await NCT02013648 results! onlinelibrary.wiley.com/doi/10.1002/jh…

The final version of our eJHaem Journal paper on intensive chemo strategies in CBF-AML is available! Alexandra Rojek #leusm -3y OS 70% and 3y EFS 51% for entire cohort -IC + GO 3y EFS 50%, IC alone 3y EFS 47%, IC + KIT inhibitor 3y EFS 85% onlinelibrary.wiley.com/doi/10.1002/jh…

Thank you KOAT for highlighting our Allogeneic Stem Cell transplant program and telling Ana's story. There's still time to support the state-of-the-art cancer treatments and research at UNMCCC by signing up for the #LoboCancerChallenge #UniteAgainstCancer koat.com/article/new-me…

Today is the Lobo Cancer Challenge! More than 1600 people signed up this year to #uniteagainstcancer

Topline results studying brexu-cel in relapsed B-ALL, now out Journal of Clinical Oncology. My thanks to Lori Muffly and partners from 30+ centers driven to answer ?s in a rare disease space. More to come. bshah Moffitt Cancer Center University of Chicago Hematology/Oncology ascopubs.org/doi/10.1200/JC…

#ASH24 Another very productive #ASH for COMMAND consortium. Presenting several abstracts on acute leukemia and myeloid disorders #leusm #mdssm #mpnsm Anand Patel Yasmin Abaza Rory M. Shallis, MD Vamsi Kota Alexander Coltoff, MD Charlie Foucar Chenyu Lin, MD et al.

Extremely proud of BloodCellsByAlexia who was awarded the David M. Goldenberg CRTI award at #ASH24 for her recognition as a CRTI participant who presented the highest scoring abstract of the international category at #ASH24. The best prize: the tools she has gained along the way

Excited to run into #AMLSM stars Anand Patel & our own Madelyn Burkart from Atrium Health Wake Forest Baptist Comprehensive Cancer Center at #ASH24! Atrium Health Levine Cancer Wake Forest Baptist - Comprehensive Cancer Center Wake Forest University School of Medicine UChicago Leukemia Program UChicagoCancerCenter Brittany Knick Ragon, MD

AML genomic data pooling between 🇺🇸MARROW consortium 🤝 🇲🇽GTLA led by Jesús G Lugo to clarify the meaning of “hispanic” #ASH24. Mexicans working together in both sides of the Rio Bravo (Grande) Nidia Zapata #Leusm

Asciminib plus dasatinib and prednisone for Philadelphia chromosome–positive acute leukemia ashpublications.org/blood/article-… by Dr. Luskin et al. #leusm #ALL 100% CR. At day 84, 100% of patients achieved complete cytogenetic remission. At day 84, 74% and 26% achieved BCR::ABL1

#lobosslamcancer Thanks to the UNM Lobos for hosting us!

A master class in BCR::ABL1-like ALL. I learned so much and am humbled by how far we have to go in this disease. pubmed.ncbi.nlm.nih.gov/39217000/

Check out this new article led by Alexandra Rojek & Anand Patel reporting outcomes in R/R CBF-AML previously treated with intensive chemotherapy! onlinelibrary.wiley.com/doi/10.1002/aj…

🚨🚨👉🏾 Latest paper from #COMMAND_consortium in American Journal of Hematology | Blood Research Journal | Wiley Online Library onlinelibrary.wiley.com/doi/10.1002/aj… Led by Alexandra Rojek and Anand Patel #RWD on outcome of RR CBF AML, allo-HCT should be considered to improve outcome.

LFGooo! The Rise, the Fall, and the Resurrection of Gemtuzumab in AML. Come listen to Bernie Marini Anthony Perissinotti Charlie Foucar and Anand Patel nerd out! #leusm #gemtuzumab #aml creators.spotify.com/pod/show/wolve…

ALLG APML5: bioavailability and safety of oral arsenic trioxide assessed during consolidation therapy for APL ashpublications.org/bloodadvances/… #leusm #APL